- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 333/64 - Atomes d'oxygène
Détention brevets de la classe C07D 333/64
Brevets de cette classe: 94
Historique des publications depuis 10 ans
|
8
|
10
|
10
|
9
|
7
|
8
|
9
|
5
|
6
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Board of Trustees of the University of Illinois | 2748 |
13 |
| Novartis AG | 10178 |
8 |
| BioCryst Pharmaceuticals, Inc. | 184 |
7 |
| Radius Pharmaceuticals, Inc. | 56 |
5 |
| Arcus Biosciences, Inc. | 165 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 875 |
4 |
| Merck Patent GmbH | 5735 |
3 |
| Genzyme Corporation | 1373 |
3 |
| Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 36 |
3 |
| Sutro Biopharma, Inc. | 184 |
3 |
| Board of Regents, The University of Texas System | 6135 |
2 |
| Antabio SAS | 23 |
2 |
| Cayman Chemical Company, Incorporated | 65 |
2 |
| Sanford Burnham Prebys Medical Discovery Institute | 310 |
2 |
| Nikang Therapeutics, Inc. | 108 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Bayer Pharma AG | 1010 |
1 |
| FUJIFILM Corporation | 30562 |
1 |
| Takeda Pharmaceutical Company Limited | 2712 |
1 |
| Cadila Healthcare Limited | 291 |
1 |
| Autres propriétaires | 26 |